Neurology · 2003 · 27 citations · 24 references
Life SciencesGeneticsMolecular GeneticsAutoimmunityNeurogeneticsNeuroimmunologyDemyelinating DiseasesDemyelinating DisordersGenetic SusceptibilityGenetic Susceptibility To AutoimmunityMultiple SclerosisNeurodegenerative DiseasesHeritable Disease SusceptibilityMultiple Sclerosis AssociationsMultiple Sclerosis ImmunopathogenesisNeurodegenerative Genetics
BACKGROUND: Both multiple sclerosis (MS) susceptibility and MS clinical phenotype are in part genetically determined. [Alpha]B-crystallin is a candidate autoantigen in MS, and there are three polymorphisms in the promoter region of the encoding gene (CRYAB): at positions -C249G, -C650G, and -A652G. METHODS: These polymorphisms were studied in sporadic cases of MS, assessing disease susceptibility, clinical phenotype, and MRI appearance. RESULTS: The CRYAB polymorphisms influenced susceptibility as well as disease expression in MS. CONCLUSION: Carriers of the rare allele CRYAB-650*C had an increased likelihood of a noninflammatory, neurodegenerative phenotype characterized by a relatively rapid, primary progressive clinical disease course.
24
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology · 1983 · 7.4K citations
A full genome search in multiple sclerosis
George C. Ebers, Kim Kukay, Dennis E. Bulman et al. · Nature Genetics · 1996 · 663 citations